Latest profit margin for G Medical Innovations Holdings Limited - Warrants (30/06/2025): -116.04% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2022
Trailing 12 months ending Jun 2022
G Medical Innovations Holdings Limited - Warrants (30/06/2025) (GMVDW) currently reports a profit margin of -116.04% as of June 2022. That compares with -554.41% in the prior-year period — up 79.1% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s profit margin history and peer comparisons.
G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s profit margin increased from -554.41% to -116.04% — a 79.1% year-over-year increase (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s profit margin of -116.04% is lower than the Healthcare sector average of 19.13%. That is roughly 706.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s current -116.04% should be judged against Healthcare norms (sector average: 19.13%) and against GMVDW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -116.04%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for G Medical Innovations Holdings Limited - Warrants (30/06/2025), and consider following GMVDW for alerts when major investors trade the stock.